Maraviroc Immune Recovery Study

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

August 31, 2012

Conditions
HIV Infections
Interventions
DRUG

maraviroc

maraviroc dose dependent on co-medication

DRUG

Placebo

Placebo drug

Trial Locations (10)

1091 AC

Onze Lieve Vrouwe Gasthuis, Amsterdam

1105AZ

Academisch Medisch Centrum (AMC), Amsterdam

Unknown

Slotervaartziekenhuis, Amsterdam

Rijnstate Hospital, Arnhem

Kennemer Gasthuis, Haarlem

Leids Universitair Medisch Centrum (LUMC), Leiden

Maasstad Ziekenhuis, Rotterdam

Sint Elisabeth Ziekenhuis, Tilburg

3015GJ

Erasmus MC, Rotterdam

3584CX

Ùniversity Medical Center Utrecht, Utrecht

Sponsors
All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Onze Lieve Vrouwe Gasthuis

OTHER

collaborator

Slotervaart Hospital

OTHER

collaborator

Rijnstate Hospital

OTHER

collaborator

Pfizer

INDUSTRY

lead

S.F.L. van Lelyveld

OTHER

NCT00875368 - Maraviroc Immune Recovery Study | Biotech Hunter | Biotech Hunter